About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

About Market Research Forecast

U.S. Hemostats Market

U.S. Hemostats Market Analysis Report 2025: Market to Grow by a CAGR of 7.2 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

U.S. Hemostats Market by Product (Active Hemostats, Passive Hemostats, Combination Hemostats, Others), by Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Others), by End User (Hospitals & ASCs, Tactical Combat Casualty Care Centers, Others), by Forecast 2026-2034

Feb 21 2025

Base Year: 2025

150 Pages

U.S. Hemostats Market Analysis Report 2025: Market to Grow by a CAGR of 7.2 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Key Insights

The U.S. Hemostats Market size was valued at USD 1.45 USD Billion in 2023 and is projected to reach USD 2.36 USD Billion by 2032, exhibiting a CAGR of 7.2 % during the forecast period. Hemostats are a class of surgical instruments, devised to control bleeding of tissues and blood vessels by closing them during surgeries. They are found in multiple variants that include Kelly, Crile, and Mosquito; characteristics such as a serrated jaw and gapping mechanism are found in each of them. These instruments allow them to be used at preceding stages of all medical treatment areas starting with general surgery and ending with periodontology and veterinary medicine. Present-day market trends in the US evince a rising necessity for the newest hemostatic devices which are equipped with ergonomic designs, enhanced Maury, and minimally invasive techniques, signifying the global development of better outcomes for surgical procedures and patients.

U.S. Hemostats Trends

Growing adoption of minimally invasive surgeries
Increasing preference for absorbable hemostats
Emergence of advanced hemostatic devices

U.S. Hemostats Market Market Size and Forecast (2024-2030) — U.S. Hemostats Market Company Market Share

Driving Forces: What's Propelling the U.S. Hemostats Market

Rising prevalence of chronic diseases: The growing incidence of cardiovascular diseases, diabetes, and cancer necessitates more surgical interventions, leading to increased demand for hemostats to control bleeding.
Expanding surgical procedures: The surge in the number of surgeries performed in the U.S. due to the aging population, evolving lifestyle choices, and advancements in surgical techniques creates a higher demand for hemostats.
Technological innovations: Continuous advancements in hemostatic agents, including the development of biodegradable, biocompatible, and targeted agents, enhance their effectiveness, safety, and ease of use, driving their adoption in various surgical and medical procedures.
Government initiatives: Government initiatives and healthcare policies that promote safe and effective surgical practices, including the adoption of advanced hemostatic technologies, further contribute to market growth.
Growing healthcare expenditure: The increasing healthcare expenditure in the U.S. provides financial resources for healthcare providers to invest in innovative and effective hemostatic products, further driving market expansion.

Challenges and Restraints in the U.S. Hemostats Market

Reimbursement challenges: Reimbursement policies can limit the use of expensive hemostats, especially in non-critical procedures.
Stringent regulatory guidelines: The strict regulatory requirements for hemostats, including FDA approval, can delay product launches and increase development costs.
Competition from alternative products: The availability of alternative bleeding control methods, such as electrosurgery and ligation, creates competition for hemostats.

Emerging Trends in U.S. Hemostats

Nanotechnology in hemostats: Nanotechnology is being used to develop hemostats with smaller sizes, higher absorption capacity, and better targeting capabilities.
Personalized hemostats: Research is ongoing to develop hemostats tailored to specific patient needs and surgical procedures, improving outcomes.
Biodegradable hemostatic agents: The development of biodegradable hemostats eliminates the need for secondary procedures to remove them, simplifying patient care.

Growth Catalysts in the U.S. Hemostats Industry

Government initiatives: Government support for research and development in hemostats can foster innovation and improve market growth.
Collaborations between companies: Partnerships between hemostat manufacturers and medical device companies can combine expertise and accelerate product development.
Expansion into emerging markets: Hemostat manufacturers are exploring opportunities in developing countries to expand their market reach.

Market Segmentation: U.S. Hemostats Analysis

Product

Active Hemostats
Passive Hemostats
Combination Hemostats
Others

Application

Trauma
Cardiovascular Surgery
General Surgery
Plastic Surgery
Orthopedic Surgery
Neurosurgery
Others

End User

Hospitals & ASCs
Tactical Combat Casualty Care Centers
Others

Leading Players in the U.S. Hemostats Market

Baxter (U.S.)
Integra LifeSciences (U.S.)
Stryker (U.S.)
Artivion, Inc. (U.S.)
BD (Becton, Dickinson, and Company) (U.S.)
Medtronic (Ireland)
Johnson & Johnson Services, Inc. (U.S.)
Pfizer Inc. (U.S.)

Significant developments in the U.S. Hemostats Sector

March 2023 – Axio Biosolutions’ Ax-Surgi Surgical Hemostat received the U.S. FDA 510(k) clearance.
January 2023 – LifeGel Absorbable Surgical Hemostat, developed by Medcura, Inc., received the U.S. FDA’s Breakthrough Device Designation.
February 2022 – Futura Surgicare Pvt. Ltd. introduced Hemostax (Oxidised Regenerated Cellulose).

Comprehensive Coverage U.S. Hemostats Market Report

For a comprehensive analysis of the U.S. hemostats market, please refer to the full report, which includes:

PEST analysis
Market size and forecast
Competitive landscape
SWOT analysis
Key industry trends
Company profiles of leading players

Regional Insight

The U.S. region remains dominant in the global hemostats market, capturing a significant share due to several contributing factors. These include:

High Prevalence of Chronic Diseases: The U.S. has a high incidence of chronic conditions such as cardiovascular diseases, diabetes, and cancer, which often lead to bleeding complications and require hemostatic interventions.
Advanced Healthcare Infrastructure: The U.S. boasts a world-class healthcare system with a wide network of hospitals, clinics, and medical facilities. This infrastructure ensures timely access to high-quality hemostatic care, particularly during surgical procedures and emergencies.
Leading Medical Technologies: The U.S. is a hub for medical innovation, with numerous research institutions and companies developing cutting-edge hemostatic technologies. These advancements have led to the availability of specialized hemostats with improved safety and efficacy.
Favorable Regulatory Framework: The U.S. regulatory landscape supports the development and approval of innovative hemostats, ensuring patient safety and encouraging research and development in the field.

Furthermore, rising healthcare expenditure, an aging population with increased healthcare needs, and a growing awareness of the importance of blood conservation in medical procedures are all contributing to the strong market performance in the U.S.

U.S. Hemostats Market Market Share by Region - Global Geographic Distribution — U.S. Hemostats Market Regional Market Share

U.S. Hemostats Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 7.2 % from 2020-2034
Segmentation	By Product Active Hemostats Passive Hemostats Combination Hemostats Others By Application Trauma Cardiovascular Surgery General Surgery Plastic Surgery Orthopedic Surgery Neurosurgery Others By End User Hospitals & ASCs Tactical Combat Casualty Care Centers Others By Geography

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Rising Technological Developments in Products to Propel Market Growth
- - 3.3. Market Restrains
  - - 3.3.1. Clinical Limitations Associated with Product to Impede Market Growth Prospects
- - 3.4. Market Trends
  - - 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. U.S. Hemostats Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product
  - 5.1.1. Active Hemostats
  - 5.1.2. Passive Hemostats
  - 5.1.3. Combination Hemostats
  - 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - by Application
  - 5.2.1. Trauma
  - 5.2.2. Cardiovascular Surgery
  - 5.2.3. General Surgery
  - 5.2.4. Plastic Surgery
  - 5.2.5. Orthopedic Surgery
  - 5.2.6. Neurosurgery
  - 5.2.7. Others
- 5.3. Market Analysis, Insights and Forecast - by End User
  - 5.3.1. Hospitals & ASCs
  - 5.3.2. Tactical Combat Casualty Care Centers
  - 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
  - 5.4.1.
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Baxter (U.S.)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Integra LifeSciences (U.S.)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Stryker (U.S)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Artivion Inc. (U.S.)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Biom'up (U.S.)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 BD (Becton Dickinson and Company) (U.S.)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Medtronic (Ireland)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Johnson & Johnson Services Inc. (U.S.)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 Pfizer Inc. (U.S.)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)

List of Figures

Figure 1: U.S. Hemostats Market Revenue Breakdown (undefined, %) by Product 2025 & 2033
Figure 2: U.S. Hemostats Market Share (%) by Company 2025

List of Tables

Table 1: U.S. Hemostats Market Revenue undefined Forecast, by Product 2020 & 2033
Table 2: U.S. Hemostats Market Volume K Units Forecast, by Product 2020 & 2033
Table 3: U.S. Hemostats Market Revenue undefined Forecast, by Application 2020 & 2033
Table 4: U.S. Hemostats Market Volume K Units Forecast, by Application 2020 & 2033
Table 5: U.S. Hemostats Market Revenue undefined Forecast, by End User 2020 & 2033
Table 6: U.S. Hemostats Market Volume K Units Forecast, by End User 2020 & 2033
Table 7: U.S. Hemostats Market Revenue undefined Forecast, by Region 2020 & 2033
Table 8: U.S. Hemostats Market Volume K Units Forecast, by Region 2020 & 2033
Table 9: U.S. Hemostats Market Revenue undefined Forecast, by Product 2020 & 2033
Table 10: U.S. Hemostats Market Volume K Units Forecast, by Product 2020 & 2033
Table 11: U.S. Hemostats Market Revenue undefined Forecast, by Application 2020 & 2033
Table 12: U.S. Hemostats Market Volume K Units Forecast, by Application 2020 & 2033
Table 13: U.S. Hemostats Market Revenue undefined Forecast, by End User 2020 & 2033
Table 14: U.S. Hemostats Market Volume K Units Forecast, by End User 2020 & 2033
Table 15: U.S. Hemostats Market Revenue undefined Forecast, by Country 2020 & 2033
Table 16: U.S. Hemostats Market Volume K Units Forecast, by Country 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Hemostats Market?

The projected CAGR is approximately 7.2 %.

2. Which companies are prominent players in the U.S. Hemostats Market?

Key companies in the market include Baxter (U.S.), Integra LifeSciences (U.S.), Stryker (U.S), Artivion, Inc. (U.S.), Biom'up (U.S.), BD (Becton, Dickinson and Company) (U.S.), Medtronic (Ireland), Johnson & Johnson Services, Inc. (U.S.), Pfizer Inc. (U.S.).

3. What are the main segments of the U.S. Hemostats Market?

The market segments include Product, Application, End User.

4. Can you provide details about the market size?

The market size is estimated to be USD XXX N/A as of 2022.

5. What are some drivers contributing to market growth?

Rising Technological Developments in Products to Propel Market Growth.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Clinical Limitations Associated with Product to Impede Market Growth Prospects.

8. Can you provide examples of recent developments in the market?

March 2023 – Axio Biosolutions’ Ax-Surgi Surgical Hemostat received the U.S. FDA 510(k) clearance. This product is chitosan-based, which can be used in controlling severe surgical bleeding.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in N/A and volume, measured in K Units.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "U.S. Hemostats Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the U.S. Hemostats Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the U.S. Hemostats Market?

To stay informed about further developments, trends, and reports in the U.S. Hemostats Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

hemostats market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033

Mexico Hemostats Market Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Industrial Hemp Market Unlocking Growth Potential: Analysis and Forecasts 2025-2033

Biodegradable Hemostat Market Soars to XX Million , witnessing a CAGR of XXX during the forecast period 2025-2033

Hempcrete Market Decade Long Trends, Analysis and Forecast 2025-2033

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report